Mediplantex Pharmaceutical Joint Stock Company (MED) received a notice from Ho Chi Minh Stock Exchange regarding its stock being warned due to incurring losses in the financial year and having negative retained earnings. MED explained that the main causes were declining revenue in the pharmaceutical manufacturing and trading sector, alongside rising raw material and operational costs. To remedy this, MED is implementing several measures: 1. Increasing investment in research and development for new products to expand scale and enhance quality. 2. Boosting marketing efforts to raise customer awareness and attract more market share. 3. Optimizing production processes to reduce costs and improve profits. 4. Strictly implementing financial management measures to reduce risks and ensure company liquidity. MED is committed to actively pursuing these measures to improve its financial situation in the near future.
Leave a Reply